5 June 2024
TruSpine Technologies
plc
("TruSpine" or the
"Company")
Convertible Loan Note
Conversion & Issue of Equity
TruSpine Technologies Plc, the
medical device company focused on the spinal (vertebral)
stabilisation market, announces that, further to the announcement
on 26 March 2024, the Company has elected to convert the Lender CLN
Subscription of £200,000 into 13,333,333 new ordinary shares at a
price of 1.5 pence per share ("CLN Shares") pursuant to the terms
of the CLN Instrument.
Admission
Application has been made for the
CLN Shares to be admitted to trading on the Aquis Stock Exchange
Growth Market on or around 11 June 2024 ("Admission"), subject to
certain resolutions being passed at the Company's forthcoming
annual general meeting to be held on 7 June 2024, and will rank
pari passu with the
ordinary shares of the Company in issue.
Total Voting Rights
Following Admission, the Company's
issued share capital will consist of 153,027,900 ordinary shares
with voting rights. The new ordinary shares will rank pari passu with the existing ordinary
shares. No ordinary shares are held in treasury at the date of this
announcement and therefore following Admission, the total number of
ordinary shares in the Company with voting rights will be
153,027,900.
This announcement contains inside
information for the purposes of the UK Market Abuse Regulation and
the Directors of the Company are responsible for the release of
this announcement.
Capitalised terms used in this
announcement shall, unless otherwise defined, have the same
meanings as set out in the Company's announcement of 26 March
2024.
Enquiries:
|
TruSpine Technologies
Plc
|
Tel: +44 (0)20 7118 0852
|
|
Geoff Miller, Non-executive
Chairman
|
|
|
|
|
|
Cairn Financial Advisers LLP
(AQSE Corporate Adviser)
|
Tel: +44
(0)20 7213 0880
|
|
Liam Murray / Ludovico
Lazzaretti
|
|
|
Peterhouse Capital Limited
(Broker & Financial Adviser)
|
Tel: +44 (0)20 7469 0930
|
|
Lucy Williams / Duncan
Vasey
|
|
|
Novus Communications (PR and
IR)
|
Tel: +44
(0)207 448 9839
|
|
Alan Green / Jacqueline
Briscoe
|
novuscomms@truspine.org
|
Caution regarding forward looking
statements
Certain statements in this
announcement, are, or may be deemed to be, forward looking
statements. Forward looking statements are identified by their use
of terms and phrases such as ''believe'', ''could'', "should"
''envisage'', ''estimate'', ''intend'', ''may'', ''plan'',
''potentially'', "expect", ''will'' or the negative of those,
variations or comparable expressions, including references to
assumptions. These forward-looking statements are not based on
historical facts but rather on the Directors' current expectations
and assumptions regarding the Company's future growth, results of
operations, performance, future capital and other expenditures
(including the amount, nature and sources of funding thereof),
competitive advantages, business prospects and opportunities. Such
forward looking statements reflect the Directors' current beliefs
and assumptions and are based on information currently available to
the Directors.
